AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...